Journal article
Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
Abstract
OBJECTIVE: Antimalarials (AM) are recommended for all systemic lupus erythematosus (SLE) patients without specific contraindications. Their main adverse effect is retinal damage; however, heart disease has been described in isolated cases. The aim of our study is to describe 8 patients with AM-induced cardiomyopathy (AMIC) in a defined SLE cohort.
METHODS: Patients attending the Toronto Lupus Clinic and diagnosed with definite (based on …
Authors
Tselios K; Deeb M; Gladman DD; Harvey P; Akhtari S; Mak S; Butany J; Urowitz MB
Journal
The Journal of Rheumatology, Vol. 46, No. 4, pp. 391–396
Publisher
The Journal of Rheumatology
Publication Date
April 2019
DOI
10.3899/jrheum.180124
ISSN
0315-162X